New Delphi Portable Oxygen Concentrator Designed to Provide Exceptional Portability to Patients

Lightweight device has the smallest footprint and package size in its class;

Innovative technology provides enhanced durability, oxygen volume and breath detection;

Agreement with evo secures distribution in North America

Today Delphi Medical Systems, a subsidiary of Delphi Corp., is introducing its new portable oxygen concentrator, the Central Air, which can help patients gain increased freedom and independence by providing exceptional durability in a lightweight package. Delphi also announced that it has entered an exclusive agreement with evo Medical Solutions to distribute the device in North America for millions of adults who require supplemental oxygen treatment after being diagnosed with chronic obstructive pulmonary disease (COPD). Currently, the device has 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Delphi’s design delivers concentrated oxygen in a compact size and convenient format, and boasts the smallest footprint and package size in its class. Measuring under a foot high and weighing less than 10 pounds, the unit allows premium portability so that patients can participate in more mobile lifestyles.

“Delphi has a rich heritage of high-quality engineering and advanced technology capabilities in both automotive and medical products,” said Francisco A. (Frank) Ordoñez, president, Delphi Product & Service Solutions. “This is a great opportunity for us to help bring portable oxygen concentrators into the mainstream with the level of reliability, quality and durability on which Delphi has built its reputation.”

“Medical research increasingly demonstrates that people can lead longer, healthier lives and reduce their healthcare costs if they’re able to maintain an active lifestyle,” said Dave Berge, managing director, Delphi Medical Systems. “The Central Air allows a significant number of patients to get back to the activities of daily living, including work, recreation and moderate exercise, as recommended by their doctor.”

The unit features a patented Delphi process that separates oxygen from room air using a unique PSA (pressure swing adsorption) cycle made practical for the first time with the use of Delphi’s advanced electronics control capabilities. This design results in improved durability and innovative package size. Delphi’s exclusive rotary compressor technology and design also enables the device to operate with less vibration than conventional compressors. Plus, Delphi’s exclusive lightweight compressor has a design life greater than any compressors used in competitive products.

Whether at home or on-the-go, the device contains several options for power so that users can conveniently access oxygen from most locations. It can be powered by the included conventional AC power supply or rechargeable battery, or via DC power, such as an automotive 12 volt power receptacle.

Included accessories, such as a carrying case and pull cart, increase the device’s versatility and allow patients to move around more readily by providing a means for safe and easy transport. The carrying case features a shoulder strap, a fabric enclosure and a clear protective cover that allows access to the control panel. With the Delphi custom fold-up cart, which features large easy-roll wheels, users can simply pull the concentrator along wherever they go.

The Central Air is available now and will be distributed in the U.S. exclusively through evo Medical Solutions’ nationwide network. evo’s president, Dan Bunting says, “Delphi has re-defined the portable oxygen market with this landmark product. We have serviced the home health respiratory market for many years, and this industry has never had a device manufacturer with the size, depth, experience and innovation of a world player like Delphi. We are eager to bring this life-changing device to our customers for their COPD patients.”

“evo’s commitment to the pursuit of technology and equipment that will help patients live a more free and active lifestyle makes this partnership ideal,” said Berge. “Together with evo, Delphi will be able to provide patients with a new, flexible option for oxygen therapy.”

evo, a manufacturer and distributor of respiratory products, is based in Iowa and serves the home health market in the U.S. and abroad.